Skip to main content
Top
Published in: Archives of Virology 11/2016

01-11-2016 | Brief Report

Bovine leukemia virus becomes established in dairy herds before the first lactation

Authors: Ramiro Merlini, Gerónimo Gutiérrez, Irene Alvarez, Juan Pablo Jaworski, Hugo Carignano, Mario Poli, Luc Willems, Karina Trono

Published in: Archives of Virology | Issue 11/2016

Login to get access

Abstract

In this work, we studied seven groups of pregnant heifers from a consortium of dairy farms heavily infected with bovine leukemia virus (BLV). ELISA testing showed that the seroprevalence ranges of BLV in heifers between 36.1 and 66.5 %. No significant differences in proviral load were found when comparing heifers with adult cattle. Before their first delivery, more than 9.8 % of heifers show a high proviral load. Because BLV infection can occur during the first two years of life, the rationale of any strategy should be to take action as early as possible after birth.
Literature
2.
go back to reference Walsh RB, Kelton DF, Hietala SK, Duffield TF (2013) Evaluation of enzyme-linked immunosorbent assays performed on milk and serum samples for detection of neosporosis and leukosis in lactating dairy cows. Can Vet J 54:347–352PubMedPubMedCentral Walsh RB, Kelton DF, Hietala SK, Duffield TF (2013) Evaluation of enzyme-linked immunosorbent assays performed on milk and serum samples for detection of neosporosis and leukosis in lactating dairy cows. Can Vet J 54:347–352PubMedPubMedCentral
8.
go back to reference Trono KG, Pérez-Filgueira DM, Duffy S, Borca MV, Carrillo C (2001) Seroprevalence of bovine leukemia virus in dairy cattle in Argentina: comparison of sensitivity and specificity of different detection methods. Vet Microbiol 83:235–248. doi:10.1016/S0378-1135(01)00420-5 CrossRefPubMed Trono KG, Pérez-Filgueira DM, Duffy S, Borca MV, Carrillo C (2001) Seroprevalence of bovine leukemia virus in dairy cattle in Argentina: comparison of sensitivity and specificity of different detection methods. Vet Microbiol 83:235–248. doi:10.​1016/​S0378-1135(01)00420-5 CrossRefPubMed
13.
go back to reference Achachi A, Florins A, Gillet N, Debacq C, Urbain P, Foutsop GM, Vandermeers F, Jasik A, Reichert M, Kerkhofs P, Lagneaux L, Burny A, Kettmann R, Willems L (2005) Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci USA 102:10309–10314. doi:10.1073/pnas.0504248102 CrossRefPubMedPubMedCentral Achachi A, Florins A, Gillet N, Debacq C, Urbain P, Foutsop GM, Vandermeers F, Jasik A, Reichert M, Kerkhofs P, Lagneaux L, Burny A, Kettmann R, Willems L (2005) Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci USA 102:10309–10314. doi:10.​1073/​pnas.​0504248102 CrossRefPubMedPubMedCentral
Metadata
Title
Bovine leukemia virus becomes established in dairy herds before the first lactation
Authors
Ramiro Merlini
Gerónimo Gutiérrez
Irene Alvarez
Juan Pablo Jaworski
Hugo Carignano
Mario Poli
Luc Willems
Karina Trono
Publication date
01-11-2016
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2016
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-2973-x

Other articles of this Issue 11/2016

Archives of Virology 11/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine